1-56912476-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000562.3(C8A):​c.1454G>T​(p.Arg485Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.062 in 1,614,080 control chromosomes in the GnomAD database, including 4,764 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R485H) has been classified as Benign.

Frequency

Genomes: 𝑓 0.10 ( 1238 hom., cov: 33)
Exomes 𝑓: 0.058 ( 3526 hom. )

Consequence

C8A
NM_000562.3 missense

Scores

2
3
12

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.252

Publications

19 publications found
Variant links:
Genes affected
C8A (HGNC:1352): (complement C8 alpha chain) C8 is a component of the complement system and contains three polypeptides, alpha, beta and gamma. This gene encodes the alpha subunit of C8. C8 participates in the formation of the membrane attack complex (MAC). The MAC assembles on bacterial membranes to form a pore, permitting disruption of bacterial membrane organization. Mutations in this gene cause complement C8 alpha-gamma deficiency. [provided by RefSeq, Nov 2008]
C8A Gene-Disease associations (from GenCC):
  • type I complement component 8 deficiency
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0047442913).
BP6
Variant 1-56912476-G-T is Benign according to our data. Variant chr1-56912476-G-T is described in ClinVar as Benign. ClinVar VariationId is 402461.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.212 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
C8ANM_000562.3 linkc.1454G>T p.Arg485Leu missense_variant Exon 10 of 11 ENST00000361249.4 NP_000553.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
C8AENST00000361249.4 linkc.1454G>T p.Arg485Leu missense_variant Exon 10 of 11 1 NM_000562.3 ENSP00000354458.3

Frequencies

GnomAD3 genomes
AF:
0.102
AC:
15558
AN:
152120
Hom.:
1236
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.216
Gnomad AMI
AF:
0.0482
Gnomad AMR
AF:
0.108
Gnomad ASJ
AF:
0.0415
Gnomad EAS
AF:
0.0519
Gnomad SAS
AF:
0.138
Gnomad FIN
AF:
0.0470
Gnomad MID
AF:
0.117
Gnomad NFE
AF:
0.0456
Gnomad OTH
AF:
0.104
GnomAD2 exomes
AF:
0.0755
AC:
18985
AN:
251300
AF XY:
0.0751
show subpopulations
Gnomad AFR exome
AF:
0.225
Gnomad AMR exome
AF:
0.0917
Gnomad ASJ exome
AF:
0.0454
Gnomad EAS exome
AF:
0.0518
Gnomad FIN exome
AF:
0.0483
Gnomad NFE exome
AF:
0.0454
Gnomad OTH exome
AF:
0.0711
GnomAD4 exome
AF:
0.0578
AC:
84527
AN:
1461842
Hom.:
3526
Cov.:
33
AF XY:
0.0596
AC XY:
43315
AN XY:
727228
show subpopulations
African (AFR)
AF:
0.228
AC:
7623
AN:
33474
American (AMR)
AF:
0.0928
AC:
4149
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0430
AC:
1125
AN:
26136
East Asian (EAS)
AF:
0.0651
AC:
2583
AN:
39700
South Asian (SAS)
AF:
0.132
AC:
11411
AN:
86258
European-Finnish (FIN)
AF:
0.0459
AC:
2451
AN:
53414
Middle Eastern (MID)
AF:
0.112
AC:
646
AN:
5766
European-Non Finnish (NFE)
AF:
0.0454
AC:
50445
AN:
1111976
Other (OTH)
AF:
0.0678
AC:
4094
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
4874
9748
14621
19495
24369
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2080
4160
6240
8320
10400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.102
AC:
15580
AN:
152238
Hom.:
1238
Cov.:
33
AF XY:
0.102
AC XY:
7590
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.216
AC:
8948
AN:
41502
American (AMR)
AF:
0.108
AC:
1655
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0415
AC:
144
AN:
3472
East Asian (EAS)
AF:
0.0518
AC:
268
AN:
5174
South Asian (SAS)
AF:
0.138
AC:
668
AN:
4826
European-Finnish (FIN)
AF:
0.0470
AC:
499
AN:
10622
Middle Eastern (MID)
AF:
0.116
AC:
34
AN:
294
European-Non Finnish (NFE)
AF:
0.0456
AC:
3104
AN:
68028
Other (OTH)
AF:
0.102
AC:
216
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
679
1358
2038
2717
3396
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
170
340
510
680
850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0350
Hom.:
32
Bravo
AF:
0.110
TwinsUK
AF:
0.0467
AC:
173
ALSPAC
AF:
0.0418
AC:
161
ESP6500AA
AF:
0.196
AC:
864
ESP6500EA
AF:
0.0430
AC:
370
ExAC
AF:
0.0774
AC:
9394
EpiCase
AF:
0.0478
EpiControl
AF:
0.0510

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
13
DANN
Uncertain
0.98
DEOGEN2
Benign
0.14
T
Eigen
Benign
-0.66
Eigen_PC
Benign
-0.84
FATHMM_MKL
Benign
0.13
N
LIST_S2
Benign
0.63
T
MetaRNN
Benign
0.0047
T
MetaSVM
Benign
-0.90
T
MutationAssessor
Pathogenic
2.9
M
PhyloP100
0.25
PrimateAI
Benign
0.20
T
PROVEAN
Pathogenic
-5.5
D
REVEL
Uncertain
0.34
Sift
Uncertain
0.0090
D
Sift4G
Benign
0.10
T
Vest4
0.11
ClinPred
0.088
T
GERP RS
0.70
Varity_R
0.66
gMVP
0.78
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1620075; hg19: chr1-57378149; COSMIC: COSV63484437; API